Global Small Animal Imaging Market Overview:
Small animal imaging involves devices and reagents used for preclinical imaging of rats and mice for the development of drugs, developmental studies, gene expression, and various other research activities. These devices are similar to imaging modalities used for diagnostic purposes in humans, however, due to the smaller size are generally referred to as microdevices. The rising number of pharmaceutical companies and clinical research organizations, increasing applications of in-vivo imaging in pre-clinical research, real-time data storage, and high-resolution modalities, are the key growth factors of the market.
Growth Drivers
- Increasing Market Demand for Noninvasive Small-Animal Imaging Techniques
- Growing Number of Public-Private Initiatives and Funding to Support Small Animal Researches
Market Trends
- Technological Advancements in the field of Molecular Imaging
Roadblocks
- Strict Regulations Governing Small Animal Research
- Significant Installation and Operational Costs Associated With Small Animal (In-Vivo) Imaging Modalities
Opportunities
- Rising Demand for the Small Animal Imaging from the Developing Economies
Challenges
- Technological and Procedural Limitations Associated With Standalone Small Animal Imaging Systems
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are PerkinElmer, Inc. (United States), Bruker Corporation (United States), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (United Kingdom), Aspect Imaging (Israel), LI-COR Biosciences (United States), Trifoil Imaging (United States) and Miltenyi Biotec GmbH (Germany). Analyst at AMA Research see United States Players to retain maximum share of Global Small Animal Imaging market by 2026. Considering Market by Reagents, the sub-segment i.e. Optical Imaging Reagents {Bioluminescent Imaging Reagents, and Fluorescent Imaging Reagents} will boost the Small Animal Imaging market. Considering Market by Modality, the sub-segment i.e. Optical Imaging Systems will boost the Small Animal Imaging market.
What Can be Explored with the Small Animal Imaging Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Small Animal Imaging Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Small Animal Imaging
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Small Animal Imaging market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Small Animal Imaging market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Small Animal Imaging Providers, Healthcare Research Institutes, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.